About

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary Communications at The Association of Investment Companies (AIC).

News

Omega Diagnostics makes German acquisition

Omega Diagnostics is to acquire the lab-based testing business of German allergy testing company Allergopharma £5.1 million.

News

Easydate set for growth

With ample cash to pursue acquisitive deals, Easydate intends to start serving up dividends too.

Financial Management

Investor AllStars 2010 in the frame

Despite the tough economic climate, a number of venture capital firms did manage to pull off some spectacular deals last year.

News

Action stations for M&A

Deals are back and that may be due to a new found pragmatism between dealmakers.

News

Google VC arm takes HomeAway stake

The venture capital arm of search engine giant Google has bought a stake in the holiday home rentals market by investing in HomeAway.

News

Green Compliance in Pestfree deal

Green Compliance has acquired Pestfree Environmental Services for £1.63 million.

News

Businesses raid savings to pay interest

British businesses are raiding their savings to pay higher interest rates on their debts, with a survey showing nearly one third are withdrawing funds to keep payments on track.

News

HgCapital sells Pulse Staffing

HgCapital has sold the healthcare recruitment company Pulse Staffing.

News

Firing up: Kristian Segerstråle

A new poster boy for the European start-up scene, Kristian Segerstråle tells GrowthBusiness how as a 33-year-old he is only getting started after the sale of his social gaming company Playfish for an initial $275 million.

News

Lloyds denies LDC sale rumour

Lloyds Banking Group has denied media speculation that it could sell off its private equity division LDC.

News

SMEs struggle to access bank finance

One in three small and medium enterprises (SMEs) can’t get a loan from their high street bank, research shows.

News

Syntaxin raises £18 million

Biotechnology company Syntaxin has raised £18 million to further develop its technology and start clinical studies on one of its products.

[this is a test deploy]